{"entity":{"type":"insider","cik":"0001818261","url":"/insider/0001818261","json_url":"/insider/0001818261.json","name":"Catinazzo Thomas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":67,"n_filings":48,"first":"2021-04-01","last":"2026-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Catinazzo Thomas","source":"filing","n_filings":48,"first_seen":"2021-04-01","last_seen":"2026-08-18"}],"transactions":[{"id":9255865,"accession":"0001193125-26-355493","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-355493","line_url":"/filing/0001193125-26-355493#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17717.0,"shares_display":"17,717","price_per_share":19.74,"price_display":"19.74","price_state":"stated","total_value":349733.58,"total_display":"349,733.58","total_whole":"349,734","shares_owned_after":140568.0,"shares_owned_after_display":"140,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-14","filed_date":"2026-08-18","scope":"insider"},{"id":5850562,"accession":"0001193125-26-326144","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-326144","line_url":"/filing/0001193125-26-326144#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1459.0,"shares_display":"1,459","price_per_share":18.61,"price_display":"18.61","price_state":"stated","total_value":27151.99,"total_display":"27,151.99","total_whole":"27,152","shares_owned_after":158285.0,"shares_owned_after_display":"158,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-28","filed_date":"2026-07-30","scope":"insider"},{"id":5930584,"accession":"0001193125-26-298679","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-298679","line_url":"/filing/0001193125-26-298679#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17717.0,"shares_display":"17,717","price_per_share":18.69,"price_display":"18.69","price_state":"stated","total_value":331130.73,"total_display":"331,130.73","total_whole":"331,131","shares_owned_after":159744.0,"shares_owned_after_display":"159,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-08","scope":"insider"},{"id":5785544,"accession":"0001193125-26-281061","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193125-26-281061","line_url":"/filing/0001193125-26-281061","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":187163.0,"shares_display":"187,163","price_per_share":16.973786432147378,"price_display":"16.97","price_state":"stated","total_value":3176864.79,"total_display":"3,176,864.79","total_whole":"3,176,865","shares_owned_after":177461.0,"shares_owned_after_display":"177,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider","n_lines":4},{"id":6062649,"accession":"0001193125-26-224545","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-224545","line_url":"/filing/0001193125-26-224545#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17717.0,"shares_display":"17,717","price_per_share":12.86,"price_display":"12.86","price_state":"stated","total_value":227840.62,"total_display":"227,840.62","total_whole":"227,841","shares_owned_after":195178.0,"shares_owned_after_display":"195,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-14","scope":"insider"},{"id":6017244,"accession":"0001193125-26-197419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-197419","line_url":"/filing/0001193125-26-197419#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":972.0,"shares_display":"972","price_per_share":14.79,"price_display":"14.79","price_state":"stated","total_value":14375.88,"total_display":"14,375.88","total_whole":"14,376","shares_owned_after":212895.0,"shares_owned_after_display":"212,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-28","filed_date":"2026-04-30","scope":"insider"},{"id":5825040,"accession":"0001193125-26-150044","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-150044","line_url":"/filing/0001193125-26-150044#line-3","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":27000.0,"total_display":"27,000.00","total_whole":"27,000","shares_owned_after":213867.0,"shares_owned_after_display":"213,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-09","filed_date":"2026-04-09","scope":"insider"},{"id":5825037,"accession":"0001193125-26-150044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-150044","line_url":"/filing/0001193125-26-150044#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17717.0,"shares_display":"17,717","price_per_share":13.01,"price_display":"13.01","price_state":"stated","total_value":230498.17,"total_display":"230,498.17","total_whole":"230,498","shares_owned_after":213867.0,"shares_owned_after_display":"213,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-09","scope":"insider"},{"id":5847338,"accession":"0001193125-26-102270","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-102270","line_url":"/filing/0001193125-26-102270#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17717.0,"shares_display":"17,717","price_per_share":10.06,"price_display":"10.06","price_state":"stated","total_value":178233.02,"total_display":"178,233.02","total_whole":"178,233","shares_owned_after":231584.0,"shares_owned_after_display":"231,584","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-11","scope":"insider"},{"id":5904391,"accession":"0001193125-26-029403","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-029403","line_url":"/filing/0001193125-26-029403#line-2","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1695.0,"shares_display":"1,695","price_per_share":8.45,"price_display":"8.45","price_state":"stated","total_value":14322.75,"total_display":"14,322.75","total_whole":"14,323","shares_owned_after":249301.0,"shares_owned_after_display":"249,301","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-28","filed_date":"2026-01-29","scope":"insider"},{"id":5904389,"accession":"0001193125-26-029403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-029403","line_url":"/filing/0001193125-26-029403#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13820.0,"shares_display":"13,820","price_per_share":7.62,"price_display":"7.62","price_state":"stated","total_value":105308.4,"total_display":"105,308.40","total_whole":"105,308","shares_owned_after":250996.0,"shares_owned_after_display":"250,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-27","filed_date":"2026-01-29","scope":"insider"},{"id":4171313,"accession":"0001193125-25-258574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-258574","line_url":"/filing/0001193125-25-258574#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21664.0,"shares_display":"21,664","price_per_share":7.29,"price_display":"7.29","price_state":"stated","total_value":157930.56,"total_display":"157,930.56","total_whole":"157,931","shares_owned_after":313631.0,"shares_owned_after_display":"313,631","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-28","filed_date":"2025-10-30","scope":"insider"},{"id":5198464,"accession":"0000950170-25-100366","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-100366","line_url":"/filing/0000950170-25-100366#line-2","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18380.0,"shares_display":"18,380","price_per_share":3.68,"price_display":"3.68","price_state":"stated","total_value":67638.4,"total_display":"67,638.40","total_whole":"67,638","shares_owned_after":335295.0,"shares_owned_after_display":"335,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-29","filed_date":"2025-07-30","scope":"insider"},{"id":5198461,"accession":"0000950170-25-100366","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-100366","line_url":"/filing/0000950170-25-100366#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1701.0,"shares_display":"1,701","price_per_share":3.74,"price_display":"3.74","price_state":"stated","total_value":6361.74,"total_display":"6,361.74","total_whole":"6,362","shares_owned_after":353675.0,"shares_owned_after_display":"353,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-28","filed_date":"2025-07-30","scope":"insider"},{"id":4194744,"accession":"0000950170-25-061366","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-061366","line_url":"/filing/0000950170-25-061366#line-4","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12943.0,"shares_display":"12,943","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":38829.0,"total_display":"38,829.00","total_whole":"38,829","shares_owned_after":355376.0,"shares_owned_after_display":"355,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-30","filed_date":"2025-04-30","scope":"insider"},{"id":4194742,"accession":"0000950170-25-061366","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-061366","line_url":"/filing/0000950170-25-061366#line-3","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3558.0,"shares_display":"3,558","price_per_share":3.23,"price_display":"3.23","price_state":"stated","total_value":11492.34,"total_display":"11,492.34","total_whole":"11,492","shares_owned_after":368319.0,"shares_owned_after_display":"368,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-29","filed_date":"2025-04-30","scope":"insider"},{"id":4194741,"accession":"0000950170-25-061366","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-061366","line_url":"/filing/0000950170-25-061366","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2690.0,"shares_display":"2,690","price_per_share":3.17,"price_display":"3.17","price_state":"stated","total_value":8527.3,"total_display":"8,527.30","total_whole":"8,527","shares_owned_after":372858.0,"shares_owned_after_display":"372,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-28","filed_date":"2025-04-30","scope":"insider","n_lines":2},{"id":4495661,"accession":"0000950170-25-047725","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-047725","line_url":"/filing/0000950170-25-047725","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4864.0,"shares_display":"4,864","price_per_share":2.84,"price_display":"2.84","price_state":"stated","total_value":13813.76,"total_display":"13,813.76","total_whole":"13,814","shares_owned_after":374567.0,"shares_owned_after_display":"374,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-27","filed_date":"2025-03-31","scope":"insider","n_lines":2},{"id":5030143,"accession":"0000950170-25-011327","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-25-011327","line_url":"/filing/0000950170-25-011327#line-5","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20791.0,"shares_display":"20,791","price_per_share":4.42,"price_display":"4.42","price_state":"stated","total_value":91896.22,"total_display":"91,896.22","total_whole":"91,896","shares_owned_after":379431.0,"shares_owned_after_display":"379,431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-01-30","scope":"insider"},{"id":5030135,"accession":"0000950170-25-011327","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-011327","line_url":"/filing/0000950170-25-011327#line-4","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2109.0,"shares_display":"2,109","price_per_share":4.55,"price_display":"4.55","price_state":"stated","total_value":9595.95,"total_display":"9,595.95","total_whole":"9,596","shares_owned_after":400222.0,"shares_owned_after_display":"400,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-29","filed_date":"2025-01-30","scope":"insider"},{"id":5030128,"accession":"0000950170-25-011327","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-011327","line_url":"/filing/0000950170-25-011327","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36036.0,"shares_display":"36,036","price_per_share":4.63,"price_display":"4.63","price_state":"stated","total_value":166846.68,"total_display":"166,846.68","total_whole":"166,847","shares_owned_after":265473.0,"shares_owned_after_display":"265,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-28","filed_date":"2025-01-30","scope":"insider","n_lines":2},{"id":2350929,"accession":"0000950170-24-141597","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-141597","line_url":"/filing/0000950170-24-141597","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4865.0,"shares_display":"4,865","price_per_share":4.417541623843782,"price_display":"4.42","price_state":"stated","total_value":21491.34,"total_display":"21,491.34","total_whole":"21,491","shares_owned_after":299226.0,"shares_owned_after_display":"299,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-27","filed_date":"2024-12-31","scope":"insider","n_lines":2},{"id":2551093,"accession":"0000950170-24-118982","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-118982","line_url":"/filing/0000950170-24-118982#line-3","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":5.95,"price_display":"5.95","price_state":"stated","total_value":13685.0,"total_display":"13,685.00","total_whole":"13,685","shares_owned_after":304091.0,"shares_owned_after_display":"304,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-29","filed_date":"2024-10-30","scope":"insider"},{"id":2551089,"accession":"0000950170-24-118982","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-118982","line_url":"/filing/0000950170-24-118982","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6802.0,"shares_display":"6,802","price_per_share":6.06,"price_display":"6.06","price_state":"stated","total_value":41220.12,"total_display":"41,220.12","total_whole":"41,220","shares_owned_after":306391.0,"shares_owned_after_display":"306,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-28","filed_date":"2024-10-30","scope":"insider","n_lines":2},{"id":2680201,"accession":"0000950170-24-110810","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-110810","line_url":"/filing/0000950170-24-110810","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6457.0,"shares_display":"6,457","price_per_share":7.462284342573951,"price_display":"7.46","price_state":"stated","total_value":48183.97,"total_display":"48,183.97","total_whole":"48,184","shares_owned_after":313193.0,"shares_owned_after_display":"313,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-10-01","scope":"insider","n_lines":2},{"id":2068108,"accession":"0000950170-24-088815","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-088815","line_url":"/filing/0000950170-24-088815","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10780.0,"shares_display":"10,780","price_per_share":8.563680890538034,"price_display":"8.56","price_state":"stated","total_value":92316.48,"total_display":"92,316.48","total_whole":"92,316","shares_owned_after":319650.0,"shares_owned_after_display":"319,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-29","filed_date":"2024-07-31","scope":"insider","n_lines":2},{"id":3111293,"accession":"0000950170-24-079689","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-079689","line_url":"/filing/0000950170-24-079689","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9373.0,"shares_display":"9,373","price_per_share":6.240629467619759,"price_display":"6.24","price_state":"stated","total_value":58493.42,"total_display":"58,493.42","total_whole":"58,493","shares_owned_after":330430.0,"shares_owned_after_display":"330,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-27","filed_date":"2024-07-01","scope":"insider","n_lines":2},{"id":2387833,"accession":"0000950170-24-050147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-050147","line_url":"/filing/0000950170-24-050147#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1695.0,"shares_display":"1,695","price_per_share":6.38,"price_display":"6.38","price_state":"stated","total_value":10814.1,"total_display":"10,814.10","total_whole":"10,814","shares_owned_after":339803.0,"shares_owned_after_display":"339,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-29","filed_date":"2024-04-29","scope":"insider"},{"id":2675903,"accession":"0000950170-24-038658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-038658","line_url":"/filing/0000950170-24-038658#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":348.0,"shares_display":"348","price_per_share":7.7,"price_display":"7.70","price_state":"stated","total_value":2679.6,"total_display":"2,679.60","total_whole":"2,680","shares_owned_after":341498.0,"shares_owned_after_display":"341,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-03-29","scope":"insider"},{"id":2888322,"accession":"0001209191-24-002472","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-002472","line_url":"/filing/0001209191-24-002472#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2005.0,"shares_display":"2,005","price_per_share":9.64,"price_display":"9.64","price_state":"stated","total_value":19328.2,"total_display":"19,328.20","total_whole":"19,328","shares_owned_after":341846.0,"shares_owned_after_display":"341,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-31","scope":"insider"},{"id":8681904,"accession":"0001209191-23-059998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059998","line_url":"/filing/0001209191-23-059998#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":294.0,"shares_display":"294","price_per_share":11.51,"price_display":"11.51","price_state":"stated","total_value":3383.94,"total_display":"3,383.94","total_whole":"3,384","shares_owned_after":143851.0,"shares_owned_after_display":"143,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-27","filed_date":"2023-12-29","scope":"insider"},{"id":7923702,"accession":"0001209191-23-054024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054024","line_url":"/filing/0001209191-23-054024#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1697.0,"shares_display":"1,697","price_per_share":6.03,"price_display":"6.03","price_state":"stated","total_value":10232.91,"total_display":"10,232.91","total_whole":"10,233","shares_owned_after":144145.0,"shares_owned_after_display":"144,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-30","filed_date":"2023-11-01","scope":"insider"},{"id":8023407,"accession":"0001209191-23-050863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050863","line_url":"/filing/0001209191-23-050863#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":294.0,"shares_display":"294","price_per_share":8.38,"price_display":"8.38","price_state":"stated","total_value":2463.72,"total_display":"2,463.72","total_whole":"2,464","shares_owned_after":145842.0,"shares_owned_after_display":"145,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"},{"id":8043634,"accession":"0001209191-23-043843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-043843","line_url":"/filing/0001209191-23-043843#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1693.0,"shares_display":"1,693","price_per_share":11.8,"price_display":"11.80","price_state":"stated","total_value":19977.4,"total_display":"19,977.40","total_whole":"19,977","shares_owned_after":146136.0,"shares_owned_after_display":"146,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-28","filed_date":"2023-07-31","scope":"insider"},{"id":7835814,"accession":"0001209191-23-040061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-040061","line_url":"/filing/0001209191-23-040061#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":294.0,"shares_display":"294","price_per_share":12.12,"price_display":"12.12","price_state":"stated","total_value":3563.28,"total_display":"3,563.28","total_whole":"3,563","shares_owned_after":147829.0,"shares_owned_after_display":"147,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-27","filed_date":"2023-06-28","scope":"insider"},{"id":9271997,"accession":"0001209191-23-033419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-033419","line_url":"/filing/0001209191-23-033419#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2012.0,"shares_display":"2,012","price_per_share":11.16,"price_display":"11.16","price_state":"stated","total_value":22453.92,"total_display":"22,453.92","total_whole":"22,454","shares_owned_after":148123.0,"shares_owned_after_display":"148,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-28","filed_date":"2023-06-01","scope":"insider"},{"id":7950538,"accession":"0001209191-23-026277","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-026277","line_url":"/filing/0001209191-23-026277#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":863.0,"shares_display":"863","price_per_share":11.16,"price_display":"11.16","price_state":"stated","total_value":9631.08,"total_display":"9,631.08","total_whole":"9,631","shares_owned_after":149272.0,"shares_owned_after_display":"149,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-28","filed_date":"2023-05-01","scope":"insider"},{"id":8744668,"accession":"0001209191-23-021420","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-021420","line_url":"/filing/0001209191-23-021420#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":347.0,"shares_display":"347","price_per_share":15.36,"price_display":"15.36","price_state":"stated","total_value":5329.92,"total_display":"5,329.92","total_whole":"5,330","shares_owned_after":150135.0,"shares_owned_after_display":"150,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-28","scope":"insider"},{"id":8018515,"accession":"0001209191-23-005700","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-005700","line_url":"/filing/0001209191-23-005700#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001818261","owner_name":"Catinazzo Thomas","owner_display_name":"Catinazzo Thomas","owner_url":"/insider/0001818261","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":864.0,"shares_display":"864","price_per_share":21.56,"price_display":"21.56","price_state":"stated","total_value":18627.84,"total_display":"18,627.84","total_whole":"18,628","shares_owned_after":150482.0,"shares_owned_after_display":"150,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-01-31","scope":"insider"}],"collapsed":true,"next_cursor":"2023-01-30|8018515","ledger_fault":false,"count":{"value":67,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":67,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":67},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001812364","name":"Relay Therapeutics, Inc.","url":"/issuer/0001812364","role":"Officer (Chief Financial Officer)","n_filings":48,"first_seen":"2021-04-01","last_seen":"2026-08-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001818261","retrieved_at":"2026-08-27T13:32:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}